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Abstract 
Background: Participation in exercise and education programs following transient ischemic attack (TIA) or 
minor stroke may decrease cardiovascular disease risk. Aims: The purpose of this study was to assess the long-
term effect (3.5y) of an exercise and education program administered soon after TIA or minor stroke diagnosis 
on clinical outcome measures (stroke classification and number, patient deaths, hospital/emergency department 
admission) and cost implications obtained from standard hospital records. Methods: Hospital records were 
screened for 60 adults (male, n=31; 71+10y), diagnosed with TIA or non-disabling stroke, who had previously 
been randomized and completed either an 8-week exercise and education program, or usual care control. 
Follow-up clinical outcomes and cost implications were obtained 3.5±0.3 years post-exercise. Results: 
Participants randomized to the exercise and education program had significantly fewer recurrent stroke/TIAs 
(n=3 vs. n=13, Cohen’s d=0.79) than the control group (P≤ 0.003). Similar finding were reported for patient 
deaths (n=0 vs. n=4, d=0.53), and hospital admissions (n=48 vs. n=102, d=0.54), although these findings were 
only approaching statistical significance.  The relative risk (mean; 95%CI) of death, stroke/TIAs and hospital 
admissions were 0.11 (0.01 to 1.98), 0.23 (0.07 to 0.72) and 0.79 (0.57 to 1.09), respectively. Hospital 
admission costs were significantly lower for the exercise group ($9,041 ± 15,080NZD [~$6,000 ± 10,000USD]) 
than the control group ($21,750 ± 22,973NZD [~$14,000 ± 15,000USD])) during the follow-up period (P<.05; 
d=0.69). Interpretation: The present study demonstrates the long-term patient benefit and economic 
importance of providing secondary prevention, exercise and education programs for patients with TIA and 
minor stroke. Clinical Trial Registration: URL: http://www.anzctr.org.au/; Trial Registration 
Number:ACTRN12611000630910 
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Introduction 
Stroke is the second most common cause of death, the primary cause of dependency, creates a huge 
societal burden and costs billions to the global economy in health and social care costs [1,2]. A transient 
ischemic attack (TIA) is an ischaemic brain attack with focal cerebral or retinal symptoms that last under 24 
hours, usually less than 1 hour [3]. Although patients with minor (non-disabling) stroke differ slightly from 
those with TIA as signs and symptoms last more than 24 hours, minor stroke patients are assessed and treated 
similarly to TIA patients to prevent a further disabling stroke, myocardial infarction or death [2,4,5]. 
Approximately 20–40% of people have a warning TIA or minor ischaemic stroke shortly before they have a 
major disabling stroke.2 The risk of stroke after TIA is between 3-10 % at 2 days, and 9-17 % at 90 days [2,6-9], 
and this is placing an ever increasing burden on health care systems. Longitudinal cohort studies have shown 
that the risk of cardiovascular events remains high (≤ 44%) 10 years post-TIA or stroke [10,11]. In addition to 
preventative measures, reducing stroke mortality and long-term disability through evidence-based acute and 
post-discharge treatments is essential to reverse the trend of increasing human, social and economic burden of 
this disease [12].  
Current guidelines for stroke/TIA recommend multifaceted interventions to aid in preventing recurrent 
events [13-15]. In this regard, short-term exercise and education programs, administered within 2 weeks of TIA 
or minor stroke diagnosis, have shown to be beneficial in improving systolic blood pressure (≤ 13 mmHg), 
diastolic blood pressure (≤ 7 mmHg), and blood lipid profile (~0.5 mmol/L for total cholesterol) [16-18]. 
Longer-term, there is evidence to suggest that these benefits are maintained up to 12 months post-intervention 
[17,18]. However, there is a paucity of research investigating long-term clinical outcome measures, such as 
hospital readmission, surgical intervention and recurrent events [14]. A recent study with patients with non-
cardioembolic mild ischemic stroke demonstrated that individuals who engaged in a 6 month exercise training, 
salt restriction and nutrition advice program experienced fewer recurrent vascular events than those in a control 
group, over a median period of 2.9 years [18]. 
Long-term follow-up data on TIA/minor stroke patients are needed to: (i) inform best-practice 
healthcare guidelines; (ii) identify optimal strategies for reversing the rising economic burden of recurrent 
events; and (iii) guide further prospective experimental research. Therefore, the purpose of this study was to 
assess the long-term (̴3.5 y post TIA/minor stroke) effect of an exercise and education program, employed soon 
after TIA/minor stroke diagnosis on: i) clinical outcome measures, and ii) the costs associated with inpatient and 
hospital admissions. 
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Methods 
Participants 
This retrospective research study involved 60 patients (male, n = 31; 71 ± 10 y), who had been 
previously diagnosed with TIA or minor (non-disabling) stroke between February and October 2011, and had 
been randomized to either an 8 week exercise and education program or to a usual care (pharmacological 
management) control condition within two weeks of initial diagnosis (see Figure 1 & Supplementary Table) 
[16,17]. TIA diagnosis was determined by a member of the clinical team, and was based upon criteria from New 
Zealand’s stroke assessment and management guidelines [13]. Clinical diagnosis of TIA was based on an 
ABCD2 score ≥ 2, while minor stroke was based on the National Institute of Health Stroke Severity Scale 
(NIHSS) score ≤ 5. A neurologist made a further designation of probable or possible stroke/TIA subtype based 
on the patient’s history, examination, and available imaging and laboratory studies using the TOAST criteria 
[19]. 
Participants were eligible to participate in the original randomized controlled trial if they had been 
diagnosed with their first TIA or minor stroke, if they lived within the local district health board catchment, and 
if they did not meet exclusion criteria. Exclusion criteria were: unstable cardiac conditions, uncontrolled 
diabetes mellitus, severe claudication, oxygen dependence, significant dementia, inability to communicate in 
English or unable to take part in exercise. Participants complied with drug treatment and standardized therapy in 
accordance with stroke physician recommendations during the period of the intervention. Of the 60 patients 
recruited to the study, only one participant received intravenous thrombolysis in the form of tissue plasminogen 
activator (tPA) as a part of their acute treatment. 
The trial was approved by New Zealand’s Central Regional Health and Disabilities Ethics Committee 
and registered with the Australian and New Zealand Clinical Trials Registry (Trial Registration Number: 
ACTRN12611000630910). Written informed consent was obtained prior to participation.  
 
Procedures 
The National Health Index number, a unique identifier that is assigned to every person who uses health 
and disability support services in New Zealand, was used, in December 2014, to access electronic health records 
for all previously recruited patients. This process was conducted by a Capital and Coast District Health Board 
(CCDHB) neurologist. Patient data was then coded by a CCDHB employee with no trial involvement to identify 
the number and type of clinical outcomes that occurred in the CCDHB public hospitals, including both inpatient 
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and outpatient visits. Clinical outcomes assessed included: stroke classification (major stroke [ischaemic stroke, 
haemorrhagic stroke], minor stroke, TIA), death, myocardial infarction, unstable angina, vascular surgery 
(coronary artery bypass graft [CABG], carotid endarterectomy, angiogram), ischaemic heart disease, peripheral 
vascular disease, congestive heart failure and hospital admissions. The medical records for each clinical 
outcome were reviewed by a CCDHB neurologist to confirm the diagnosis. A cost analysis was undertaken 
when a patient was: i) in the emergency department for more than 6 hours, or ii) admitted to the inpatient 
hospital ward. The cost of each presentation was calculated using the Weighted Inlier Equivalent Separations 
(WIES) amount, which is a cost unit based on the disease-related group (i.e., stroke disease-related group 
includes ischaemic stroke, intra-cerebral haemorrhage) and the casemix (complexity of patient illness) used to 
fund public hospitals in New Zealand.  
 
Statistical analysis 
 Pearson Chi-squared tests and independent-samples t-tests compared baseline descriptive statistics of 
exercise and control group participants. Following this, a series of one-way analyses of variance, whereby 
clinical outcome measures reported at follow-up (e.g., number of strokes, myocardial infarction, 
hospitalisations) were included as the dependent variable, the group (exercise vs. control) was included as the 
fixed factor, and potentially pertinent baseline measures (i.e., number of participants with hypertension, high 
cholesterol, diabetes, heart problems), as presented elsewhere [16], were included as covariates. As the above 
covariates had no significant bearing on the clinical outcome measures, a series of independent samples t-tests 
were used to compare the number of people who presented at hospital with a clinical outcome measure which 
was reported during the follow-up period, for each group (exercise vs. control). Levene’s test for equality of 
variance was used to determine whether the assumption of homogeneity of variance had been violated, while a 
Bonferroni correction factor was used to reduce the risk of Type I error. Cohen’s d was used to identify the 
effect size, whereby 0.2, 0.5 and 0.8 represents a small, moderate and large effect [20]. An identical analysis 
was used to assess the cost implications of patient visits to the hospital during the follow-up period. 
The relative risk (RR), standard error of the log relative risk (SE) and 95% confidence interval (CI) 
were calculated [21]. Although RR does not imply causation, it is a useful measure to demonstrate an intended 
association between treatment and effect. A RR of 1.0 demonstrates that there is no difference in risk between 
the treatment (exercise and education) and control groups. A RR < 1 means that the event is less likely to occur 
in the treatment group than in the control group, while a RR > 1 means that the event is more likely to occur in 
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the treatment group than in the control group. Lastly, as a marker of clinical significance, the number needed to 
treat (NNT) was calculated to estimate the number of patients who need to use the new treatment (exercise and 
education), rather than the standard treatment (usual care control group), to prevent one clinical outcome [22]. 
 
Results 
As previously demonstrated [16], there were no between-group differences in demographic 
characteristics, stroke etiology, history of CVD, lifestyle, and medication use at baseline (all P > .05; Table 1). 
Table 2 summarises the number of patients who presented with clinical outcomes within the 3.5 ± 0.3 year 
follow-up period. During this period of assessment, participants randomised to the exercise and education 
intervention had significantly fewer recurrent strokes/TIAs, than those in the control group (P < .05; Table 2). 
Moderate to large effect sizes were reported for a number of outcome measures including the prevalence of 
recurrent strokes/TIAs, deaths, and hospital admissions (Cohen’s d between 0.53 and 0.80; Table 2, Figure 2). 
Hospital admission costs were significantly lower for the exercise and education group (n = 18; $9,041 ± 15,080 
NZD [~6,000 ± 10,000 USD]) than the control group (n = 23; $21,750 ± 22,973 NZD [~$14,000 ± 15,000 
USD]) during the assessment period (P < .05; Cohen’s d = 0.69). As shown in Table 3, the RR for all markers of 
interest were < 1, demonstrating that adverse events were less likely to occur in those randomized to the 
exercise and education intervention. In addition, the NNT to ensure a patient benefit was relatively low.   
 
Discussion 
This study demonstrated that patients who engaged in an exercise and education program soon after 
TIA/stroke diagnosis had fewer strokes and/or recurrent TIAs within the follow-up period than those patients 
who were provided usual care (control) treatment after their initial diagnosis. Furthermore, patients presented at 
hospital on fewer occasions, and hospital admission costs were, on average, lower for the exercise and education 
group than the control group during the follow-up period. These findings may be important when considering 
the long-term patient benefit and decreased economic burden associated with TIA and minor stroke patients 
engaging in an exercise and education program. 
As reported elsewhere [16], two patients in each group (exercise and education vs. control) experienced 
a recurrent TIA within 8-weeks of being randomized. When considering the longer-term follow-up data, which 
includes the statistics reported above, of the patients who took part in the exercise and education program, only 
three patients (10 %) experienced a recurrent stroke or TIA during the 3.5 year follow-up period (Table 2). In 
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contrast, thirteen (43 %) of the patients who were randomized to the usual care control group presented with a 
recurrent stroke or TIA. The statistical difference in the prevalence of ‘all’ strokes in the follow-up period is 
further supported by the large effect size, the small RR for the treatment (exercise and education) condition and 
the small number of patients required to demonstrate treatment benefit. When considering the latter, the present 
study suggests that for every three patients that engage in an exercise and education program rather than usual 
care, one patient will benefit. Encouraging trends were also evident when assessing the frequency of minor 
stroke and recurrent TIAs (Table 1 & 2); an interesting finding when considering that previous research has 
demonstrated high rates of TIA following an initial stroke/TIA episode [8,9]. The findings from the present 
study are in contrast to a recent meta-analysis which demonstrated no difference in the odds of stroke/TIA re-
occurrence when patients engaged in a lifestyle management intervention compared to receiving usual care [14]. 
The high heterogeneity of the meta-analyses’ study sample may offer some reasoning for this difference.   
There are a number of reasons as to why those who participated in the exercise program may have a 
lower risk of reoccurring stroke. Exercise, for example, has been shown to: i) improve functional capacity by 
increasing aerobic fitness, strength, balance, flexibility and mobility, ii) reduce the risk of cardio- and 
cerebrovascular disease by reducing blood pressure, and by improving blood lipid profile, glucose regulation, 
insulin sensitivity and anthropometric profile, and iii) provide psychological benefits through improving quality 
of life, enabling physical independence and by reducing stress and anxiety [23-26]. Importantly, such 
physiological and psychological changes may also reduce the risk of other co-morbid conditions such as 
diabetes, obesity and metabolic syndrome. 
The meta-analysis by Lawrence and colleagues [14] has previously shown no significant differences in 
the odds of death between those partaking in lifestyle management interventions compared to those randomized 
to a usual care control group. The small number of studies investigated (n = 4), the different lifestyle 
management interventions employed, and the varying population groups assessed, may be an underpinning 
reason for this finding. In our study, there does appear to be pragmatic benefit of implementing a secondary 
prevention exercise and education program soon after initial diagnosis as significantly fewer  deaths occurred 
during the 3.5 year follow-up period (Table 2 and 3). Based on the findings from our study, there is a pressing 
need for large, multi-site randomized controlled trials, with a significant follow-up period (> 12 months) to 
ascertain the utility of lifestyle management interventions (i.e., exercise and education) in this population group. 
Our study emphasises the importance of implementing larger trials as despite the above favourable findings in 
terms of the prevalence of strokes/TIAs, death and hospitalisations, in total there were slightly more cardiac-
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related complications (e.g., myocardial infarction, unstable angina, ischaemic heart disease, peripheral vascular 
disease, congestive heart failure) for those randomized to the exercise and education group (n = 15) compared to 
the control group (n = 11). 
The present study provides preliminary evidence that early exercise and education engagement could 
significantly reduce the economic burden associated with recurrent vascular events post-stroke/TIA [2]. This 
study has shown that the costs associated with hospital admissions were 141% higher in the usual care control 
group compared to those randomized to the exercise and education program. The difference in cost analysis is 
strongly associated with the number of hospital admissions during the follow-up period. In this study, 67% of 
patients in the exercise and education group presented at hospital, of which there were only 48 visits in total 
over a 3.5 year period. In contrast, 80% (n = 24) of those individuals in the control group presented at hospital, 
of which there were 102 visits in total (Table 2, Figure 1). The moderate effect size and small number of 
patients required to demonstrate a treatment benefit (Table 3) provides further support for the implementation of 
an exercise and education program. When considering the time and cost of consultants, nurses, practitioners and 
technicians, the cost of imaging and equipment use (CT scans, etc.) and possible medicinal intervention [2], a 
simple exercise and education intervention employed soon after diagnosis could have significant long-term 
financial benefit by reducing the number of follow-up hospital admissions. 
Although the present study has shown favourable changes in specific clinical outcomes in those who 
engaged in the exercise and education programme, it is pertinent to recognise the potential limitations of the 
study. First of all, this is a retrospective study with a small sample size. The original study by Faulkner and 
colleagues [16] was designed and powered to assess the effect of an 8-week exercise and education program on 
short-term cardiovascular risk factors (e.g., blood pressure, total blood lipid profile), not long-term clinical 
outcome measures. Secondly, it is difficult to determine an exact cause and effect, as we did not monitor 
patients consistently during the follow-up period. For example, physical activity participation, nutrition, sleep 
and psycho-social markers of health were not assessed during the follow-up period. Also, the relative risk data 
presented in this paper only describes an intended association between treatment and effect, and not causation. 
In addition, the research team were unable to ascertain pharmacological management during follow-up. 
Although previous research has shown no differences in medication at 12 months between an exercise and usual 
care control group [17], we should not necessarily assume that this is the case at 3.5 years. It is also evident, 
retrospectively, that clinicians found it challenging to provide a specific stroke etiology for a number of the 
participants (Table 1). 
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In conclusion, the present study has demonstrated that those patients who engaged in an exercise and 
education program soon after initial stroke/TIA diagnosis presented at hospital on fewer occasions, and 
experienced fewer recurrent strokes/TIAs and death, than those who received usual care over the course of a 3.5 
year follow-up period. These findings, in combination with the lower financial implications, are highly pertinent 
when considering the long-term patient benefit and decreased economic burden associated with TIA and minor 
stroke patients engaging in an exercise and education program.  
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Table and Figure Legend: 
Table 1: Demographic and other characteristics for exercise and control groups 
Table 2: Clinical outcomes reported for exercise and control groups following a 3.5 year follow-up period. 
Values are reported as number of people or events, and as a percentage of the study sample 
Table 3: Relative risk and numbers needed to treat (NNT) for key clinical outcomes reported from Table 1 
 
Figure 1 Participant recruitment 
Figure 2: Hospital admissions during a 3.5 year follow-up period 
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Table 1: Demographic and other characteristics for exercise and control groups  
               Exercise                             Control                 P value 
  n % n %  
Participants (n)  30 50 30 50  
Age (y)  68 ± 11  69 ± 10  0.370 
Gender (n) Male 16 53 15 50 0.501 
 Female 14 47 15 50  
Descent (n) European 27 90 26 87 0.490 
 Maori 1 3 0 0  
 Pacifica 1 3 2 7  
 Asian 1 3 1 3  
 Indian 0 0 1 3  
Stroke subtype Small vessel lacunar 16 53 18 60 0.848 
 Large artery atherosclerosis 3 10 1 3  
 Cardioembolic 3 10 3 10  
 Undetermined 8 27 8 27  
Family history of CVD Myocardial infarction 14 47 16 53 0.904 
 Heart surgery 4 13 4 13 1.000 
 Stent 1 3 3 10 0.068 
 Catheter 0 0 3 10 0.171 
 Heart defect 3 10 1 3 0.319 
 Stroke 12 40 13 43 1.000 
Personal history of CVD Hypertension 18 60 23 77 0.451 
 High cholesterol 15 50 19 63 0.644 
 Diabetes 4 13 7 23 0.411 
 Artery diseases 3 10 4 13 1.000 
 Thyroid disease 0 0 1 3 0.567 
 Lung disease 2 7 2 7 1.000 
 Asthma 6 20 5 17 0.561 
 Cancer 5 17 8 27 0.439 
 Kidney disease 3 10 2 7 0.673 
 Hepatitis 2 7 1 3 0.586 
Signs & symptoms of CVD Chest pain 10 33 11 37 1.000 
 Dyspnea 18 60 17 57 0.492 
 Heart palpitations 10 33 9 30 0.624 
 Skipped heart beats 9 30 7 23 0.434 
 Heart murmur 2 7 4 13 0.498 
 Intermittent leg-pain 9 30 12 40 0.640 
 Syncope 17 57 12 40 0.068 
 Fatigue  12 40 15 50 0.655 
 Snoring 10 33 17 57 0.167 
 Back pain 12 40 16 53 0.499 
Lifestyle factors Current Smoker 2* 7 3† 10 1.000 
 Duration smoking (y) 54 ± 8  35 ± 15  0.213 
 Previous Smoker 18 60 17 57 0.492 
 Quit duration (y) 28 ± 18  28 ± 12  0.992 
 Alcohol consumption 20 66 19 63 0.476 
 Current Weight Loss Plan  1 3 2 7 0.675 
 Everyday Activity: Sedentary 9 30 6 20 0.745 
                                   Light 11 37 17 57  
                                   Moderate 7 23 7 23  
                                  Vigorous 1 3 1 3  
Medication Statins 25 83 25  83  
 Antithrombotic 26 87 23  77  
 ACEI 9 30 14  47  
 Diuretics 8 27 11  37  
 Calcium blockers 9 30 7  23  
 Beta blockers 7 23 5  17  
 Anticoagulants 2 7 4 13  
 Other Anti-hypertensives 2 7 1  3  
 Mean medication use 2.87 ± 1.07  2.85 ± 1.01  0.887 
 
Pack years; * Current smokers who smoke between 0.5 and 1.0 pack per day 
     † Current smokers who smoke < 0.5 packs per day 
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Table 2: Clinical outcomes reported for exercise and control groups following a 3.5 year follow-up period. Values are reported as number of people or events, and as a 
percentage of the study sample 
   
Exercise Control t P ES 
   
People 
 (n) % 
Total events  
(n) People (n) % 
Total events 
 (n) 
   Stroke diagnosis Major stroke  Ischaemic stroke 0 0 0 0 0 0 -1.439 0.155 3.72 
  
ICH 0 0 0 2 7 2 
   
 
Minor stroke 
 
1 3 1 5 17 6 -1.764 0.083 0.45 
 
TIA 
 
2 7 5 6 20 10 1.828 0.074 0.45 
 Total (major stroke, minor stroke, TIA) 3^ 10 6 13# 43 18 -3.099 0.003* 0.80 
MI 
  
2 7 2 1 3 1 0.557 0.581 1.38 
Unstable Angina 
  
1 3 1 1 3 1 0.000 1.000 0.00 
Death 
  
0 0 0 4 13 4 -2.112 0.043# 0.53 
CEA 
  
4 13 4 1 3 1 1.401 0.167 1.64 
Revascularisation 
  
1 3 1 1 3 1 0.000 1.000 0.00 
Angiogram 
  
3 10 3 2 7 2 0.460 0.647 0.11 
CABG 
  
1 3 1 1 3 1 0.000 1.000 0.00 
IHD 
  
7 23  8 27  -0.293 0.770 0.09 
PVD 
  
2 7  1 3  0.584 0.561 014 
CHF 
  
3 10  0 0  1.795 0.083 0.46 
Hospital admissions† 
  
20 67 48 24 80 104 -2.098 0.041# 0.54 
Abbreviations: CABG, Coronary artery bypass graft; CEA, Carotid endarterectomy; CHF, Congestive heart failure; ICH, Intra-cerebral haemorrhage; IHD, Ischaemic heart 
disease; MI, Myocardial infarction; PVD, Peripheral vascular disease; TIA, Transient Ischaemic Attack 
N.B. *Significant difference between groups (P ≤ 0.003); ^ Of the three patients in the exercise group who experienced a stroke or TIA, only one of these patients 
experienced multiple events. #Of the thirteen control group patients who experienced a stroke or TIA, two patients experienced multiple events.† ED admissions are analysed 
in relation to the total number of events. 
#Approaching a significant difference between groups (P < .05) 
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Table 3: Relative risk and numbers needed to treat (NNT) for key clinical outcomes reported from Table 1 
  Relative risk 95%CI NNT (n) 
Stroke diagnosis Major stroke (ischaemic stroke, ICH) 0.20 0.01 to 3.99 16 
 Minor stroke 0.20 0.02 to 1.61 8 
 TIA 0.33 0.07 to 1.52 8 
 Total (major stroke, minor stroke, TIA) 0.23 0.07 to 0.72 3 
Death  0.11 0.01 to 1.98 8 
Hospital admissions  0.79 0.57 to 1.09 6 
 
Abbreviations: CI, Confidence interval; ICH, Intra-cerebral haemorrhage; NNT, Numbers needed to treat; TIA, Transient Ischaemic Attack 
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